These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 19441904)

  • 41. SIRT1: linking adaptive cellular responses to aging-associated changes in organismal physiology.
    Anastasiou D; Krek W
    Physiology (Bethesda); 2006 Dec; 21():404-10. PubMed ID: 17119153
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oxadiazole-carbonylaminothioureas as SIRT1 and SIRT2 inhibitors.
    Huhtiniemi T; Suuronen T; Rinne VM; Wittekindt C; Lahtela-Kakkonen M; Jarho E; Wallén EA; Salminen A; Poso A; Leppänen J
    J Med Chem; 2008 Aug; 51(15):4377-80. PubMed ID: 18642893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins).
    Trapp J; Meier R; Hongwiset D; Kassack MU; Sippl W; Jung M
    ChemMedChem; 2007 Oct; 2(10):1419-31. PubMed ID: 17628866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular cloning and characterization of porcine sirtuin genes.
    Jin D; Tan HJ; Lei T; Gan L; Chen XD; Long QQ; Feng B; Yang ZQ
    Comp Biochem Physiol B Biochem Mol Biol; 2009 Aug; 153(4):348-58. PubMed ID: 19389481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin.
    Schuetz A; Min J; Antoshenko T; Wang CL; Allali-Hassani A; Dong A; Loppnau P; Vedadi M; Bochkarev A; Sternglanz R; Plotnikov AN
    Structure; 2007 Mar; 15(3):377-89. PubMed ID: 17355872
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The anti-aging, metabolism potential of SIRT1.
    Ghosh HS
    Curr Opin Investig Drugs; 2008 Oct; 9(10):1095-102. PubMed ID: 18821472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chromosomal characterization and localization of the NAD+-dependent histone deacetylase gene sirtuin 1 in the mouse.
    Mahlknecht U; Voelter-Mahlknecht S
    Int J Mol Med; 2009 Feb; 23(2):245-52. PubMed ID: 19148549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bisnaphthalimidopropyl derivatives as inhibitors of Leishmania SIR2 related protein 1.
    Tavares J; Ouaissi A; Kong Thoo Lin P; Loureiro I; Kaur S; Roy N; Cordeiro-da-Silva A
    ChemMedChem; 2010 Jan; 5(1):140-7. PubMed ID: 19937668
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1.
    Napper AD; Hixon J; McDonagh T; Keavey K; Pons JF; Barker J; Yau WT; Amouzegh P; Flegg A; Hamelin E; Thomas RJ; Kates M; Jones S; Navia MA; Saunders JO; DiStefano PS; Curtis R
    J Med Chem; 2005 Dec; 48(25):8045-54. PubMed ID: 16335928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Medicine. The yin-yang of sirtuins.
    Dillin A; Kelly JW
    Science; 2007 Jul; 317(5837):461-2. PubMed ID: 17656709
    [No Abstract]   [Full Text] [Related]  

  • 51. Sirtuin 1 overexpression mice show a reference memory deficit, but not neuroprotection.
    Kakefuda K; Fujita Y; Oyagi A; Hyakkoku K; Kojima T; Umemura K; Tsuruma K; Shimazawa M; Ito M; Nozawa Y; Hara H
    Biochem Biophys Res Commun; 2009 Oct; 387(4):784-8. PubMed ID: 19643082
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel sirtuin 2 (SIRT2) inhibitor with p53-dependent pro-apoptotic activity in non-small cell lung cancer.
    Hoffmann G; Breitenbücher F; Schuler M; Ehrenhofer-Murray AE
    J Biol Chem; 2014 Feb; 289(8):5208-16. PubMed ID: 24379401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic potential of sirtuin-activating compounds in Alzheimer's disease.
    Gan L
    Drug News Perspect; 2007 May; 20(4):233-9. PubMed ID: 17637936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thiobarbiturates as sirtuin inhibitors: virtual screening, free-energy calculations, and biological testing.
    Uciechowska U; Schemies J; Neugebauer RC; Huda EM; Schmitt ML; Meier R; Verdin E; Jung M; Sippl W
    ChemMedChem; 2008 Dec; 3(12):1965-76. PubMed ID: 18985648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress.
    Inoue T; Hiratsuka M; Osaki M; Yamada H; Kishimoto I; Yamaguchi S; Nakano S; Katoh M; Ito H; Oshimura M
    Oncogene; 2007 Feb; 26(7):945-57. PubMed ID: 16909107
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence.
    Albani D; Polito L; Forloni G
    J Alzheimers Dis; 2010; 19(1):11-26. PubMed ID: 20061622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is Sirt1 a miracle bullet for longevity?
    Imai S
    Aging Cell; 2007 Dec; 6(6):735-7. PubMed ID: 17941969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and characterization of proteins interacting with SIRT1 and SIRT3: implications in the anti-aging and metabolic effects of sirtuins.
    Law IK; Liu L; Xu A; Lam KS; Vanhoutte PM; Che CM; Leung PT; Wang Y
    Proteomics; 2009 May; 9(9):2444-56. PubMed ID: 19343720
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sirtuin gene expression in human mononuclear cells is modulated by caloric restriction.
    Crujeiras AB; Parra D; Goyenechea E; Martínez JA
    Eur J Clin Invest; 2008 Sep; 38(9):672-8. PubMed ID: 18837744
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human SIRT1: a potential biomarker for tumorigenesis?
    Lim CS
    Cell Biol Int; 2007 Jun; 31(6):636-7. PubMed ID: 17433727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.